Skip to main content
Premium Trial:

Request an Annual Quote

It Makes Sense that Personalized Medicine Would Look a Little Frenzied

If you remember the days of Genaissance Pharmaceuticals, this post's for you: Gualberto Ruaño, CEO of that company (and now both director of genetics research at Hartford Hospital and president of Genomas), stars in this brief article from today's New York Times. The story covers a digital collage of genome sequences that's on the cover of the latest issue of Connecticut Medicine. It was chosen by Ruaño and his team as a way to promote personalized medicine, according to the article.


The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.